Assessing changes in vascular permeability in a hamster model of viral hemorrhagic fever

Brian B. Gowen, Justin G. Julander, Nyall London, Min Hui Wong, Deanna Larson, John D. Morrey, Dean Y. Li, Mike Bray

Research output: Contribution to journalArticle

Abstract

Background. A number of RNA viruses cause viral hemorrhagic fever (VHF), in which proinflammatory mediators released from infected cells induce increased permeability of the endothelial lining of blood vessels, leading to loss of plasma volume, hypotension, multi-organ failure, shock and death. The optimal treatment of VHF should therefore include both the use of antiviral drugs to inhibit viral replication and measures to prevent or correct changes in vascular function. Although rodent models have been used to evaluate treatments for increased vascular permeability (VP) in bacterial sepsis, such studies have not been performed for VHF. Results. Here, we use an established model of Pichinde virus infection of hamsters to demonstrate how changes in VP can be detected by intravenous infusion of Evans blue dye (EBD), and compare those measurements to changes in hematocrit, serum albumin concentration and serum levels of proinflammatory mediators. We show that EBD injected into sick animals in the late stage of infection is rapidly sequestered in the viscera, while in healthy animals it remains within the plasma, causing the skin to turn a marked blue color. This test could be used in live animals to detect increased VP and to assess the ability of antiviral drugs and vasoactive compounds to prevent its onset. Finally, we describe a multiplexed assay to measure levels of serum factors during the course of Pichinde arenavirus infection and demonstrate that viremia and subsequent increase in white blood cell counts precede the elaboration of inflammatory mediators, which is followed by increased VP and death. Conclusions. This level of model characterization is essential to the evaluation of novel interventions designed to control the effects of virus-induced hypercytokinemia on host vascular function in VHF, which could lead to improved survival.

Original languageEnglish (US)
Article number240
JournalVirology Journal
Volume7
DOIs
StatePublished - Sep 20 2010
Externally publishedYes

Fingerprint

Viral Hemorrhagic Fevers
Capillary Permeability
Cricetinae
Blood Vessels
Evans Blue
Antiviral Agents
Arenaviridae Infections
Pichinde virus
Coloring Agents
Viscera
Plasma Volume
Viremia
RNA Viruses
Virus Diseases
Serum
Leukocyte Count
Hematocrit
Intravenous Infusions
Serum Albumin
Hypotension

ASJC Scopus subject areas

  • Virology
  • Infectious Diseases

Cite this

Gowen, B. B., Julander, J. G., London, N., Wong, M. H., Larson, D., Morrey, J. D., ... Bray, M. (2010). Assessing changes in vascular permeability in a hamster model of viral hemorrhagic fever. Virology Journal, 7, [240]. https://doi.org/10.1186/1743-422X-7-240

Assessing changes in vascular permeability in a hamster model of viral hemorrhagic fever. / Gowen, Brian B.; Julander, Justin G.; London, Nyall; Wong, Min Hui; Larson, Deanna; Morrey, John D.; Li, Dean Y.; Bray, Mike.

In: Virology Journal, Vol. 7, 240, 20.09.2010.

Research output: Contribution to journalArticle

Gowen, Brian B. ; Julander, Justin G. ; London, Nyall ; Wong, Min Hui ; Larson, Deanna ; Morrey, John D. ; Li, Dean Y. ; Bray, Mike. / Assessing changes in vascular permeability in a hamster model of viral hemorrhagic fever. In: Virology Journal. 2010 ; Vol. 7.
@article{c1900f8a44af499092ad0c7f99df90fe,
title = "Assessing changes in vascular permeability in a hamster model of viral hemorrhagic fever",
abstract = "Background. A number of RNA viruses cause viral hemorrhagic fever (VHF), in which proinflammatory mediators released from infected cells induce increased permeability of the endothelial lining of blood vessels, leading to loss of plasma volume, hypotension, multi-organ failure, shock and death. The optimal treatment of VHF should therefore include both the use of antiviral drugs to inhibit viral replication and measures to prevent or correct changes in vascular function. Although rodent models have been used to evaluate treatments for increased vascular permeability (VP) in bacterial sepsis, such studies have not been performed for VHF. Results. Here, we use an established model of Pichinde virus infection of hamsters to demonstrate how changes in VP can be detected by intravenous infusion of Evans blue dye (EBD), and compare those measurements to changes in hematocrit, serum albumin concentration and serum levels of proinflammatory mediators. We show that EBD injected into sick animals in the late stage of infection is rapidly sequestered in the viscera, while in healthy animals it remains within the plasma, causing the skin to turn a marked blue color. This test could be used in live animals to detect increased VP and to assess the ability of antiviral drugs and vasoactive compounds to prevent its onset. Finally, we describe a multiplexed assay to measure levels of serum factors during the course of Pichinde arenavirus infection and demonstrate that viremia and subsequent increase in white blood cell counts precede the elaboration of inflammatory mediators, which is followed by increased VP and death. Conclusions. This level of model characterization is essential to the evaluation of novel interventions designed to control the effects of virus-induced hypercytokinemia on host vascular function in VHF, which could lead to improved survival.",
author = "Gowen, {Brian B.} and Julander, {Justin G.} and Nyall London and Wong, {Min Hui} and Deanna Larson and Morrey, {John D.} and Li, {Dean Y.} and Mike Bray",
year = "2010",
month = "9",
day = "20",
doi = "10.1186/1743-422X-7-240",
language = "English (US)",
volume = "7",
journal = "Virology Journal",
issn = "1743-422X",
publisher = "BioMed Central",

}

TY - JOUR

T1 - Assessing changes in vascular permeability in a hamster model of viral hemorrhagic fever

AU - Gowen, Brian B.

AU - Julander, Justin G.

AU - London, Nyall

AU - Wong, Min Hui

AU - Larson, Deanna

AU - Morrey, John D.

AU - Li, Dean Y.

AU - Bray, Mike

PY - 2010/9/20

Y1 - 2010/9/20

N2 - Background. A number of RNA viruses cause viral hemorrhagic fever (VHF), in which proinflammatory mediators released from infected cells induce increased permeability of the endothelial lining of blood vessels, leading to loss of plasma volume, hypotension, multi-organ failure, shock and death. The optimal treatment of VHF should therefore include both the use of antiviral drugs to inhibit viral replication and measures to prevent or correct changes in vascular function. Although rodent models have been used to evaluate treatments for increased vascular permeability (VP) in bacterial sepsis, such studies have not been performed for VHF. Results. Here, we use an established model of Pichinde virus infection of hamsters to demonstrate how changes in VP can be detected by intravenous infusion of Evans blue dye (EBD), and compare those measurements to changes in hematocrit, serum albumin concentration and serum levels of proinflammatory mediators. We show that EBD injected into sick animals in the late stage of infection is rapidly sequestered in the viscera, while in healthy animals it remains within the plasma, causing the skin to turn a marked blue color. This test could be used in live animals to detect increased VP and to assess the ability of antiviral drugs and vasoactive compounds to prevent its onset. Finally, we describe a multiplexed assay to measure levels of serum factors during the course of Pichinde arenavirus infection and demonstrate that viremia and subsequent increase in white blood cell counts precede the elaboration of inflammatory mediators, which is followed by increased VP and death. Conclusions. This level of model characterization is essential to the evaluation of novel interventions designed to control the effects of virus-induced hypercytokinemia on host vascular function in VHF, which could lead to improved survival.

AB - Background. A number of RNA viruses cause viral hemorrhagic fever (VHF), in which proinflammatory mediators released from infected cells induce increased permeability of the endothelial lining of blood vessels, leading to loss of plasma volume, hypotension, multi-organ failure, shock and death. The optimal treatment of VHF should therefore include both the use of antiviral drugs to inhibit viral replication and measures to prevent or correct changes in vascular function. Although rodent models have been used to evaluate treatments for increased vascular permeability (VP) in bacterial sepsis, such studies have not been performed for VHF. Results. Here, we use an established model of Pichinde virus infection of hamsters to demonstrate how changes in VP can be detected by intravenous infusion of Evans blue dye (EBD), and compare those measurements to changes in hematocrit, serum albumin concentration and serum levels of proinflammatory mediators. We show that EBD injected into sick animals in the late stage of infection is rapidly sequestered in the viscera, while in healthy animals it remains within the plasma, causing the skin to turn a marked blue color. This test could be used in live animals to detect increased VP and to assess the ability of antiviral drugs and vasoactive compounds to prevent its onset. Finally, we describe a multiplexed assay to measure levels of serum factors during the course of Pichinde arenavirus infection and demonstrate that viremia and subsequent increase in white blood cell counts precede the elaboration of inflammatory mediators, which is followed by increased VP and death. Conclusions. This level of model characterization is essential to the evaluation of novel interventions designed to control the effects of virus-induced hypercytokinemia on host vascular function in VHF, which could lead to improved survival.

UR - http://www.scopus.com/inward/record.url?scp=77956570798&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77956570798&partnerID=8YFLogxK

U2 - 10.1186/1743-422X-7-240

DO - 10.1186/1743-422X-7-240

M3 - Article

C2 - 20846417

AN - SCOPUS:77956570798

VL - 7

JO - Virology Journal

JF - Virology Journal

SN - 1743-422X

M1 - 240

ER -